Simonian Nancy A - Insider Non-Derivative Transactions at Syros Pharmaceuticals, Inc. (SYRS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 2, 2024, Simonian Nancy A's relationship to Syros Pharmaceuticals, Inc. (SYRS) is Director, and currently has 4,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SYRS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Simonian Nancy A - Insider Non-Derivative Transactions of SYRS Common Stock

Simonian Nancy A - Insider Non-Derivative Transactions at SYRS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 3, 2024	Sell -- (Common Stock)	37070	0.27	4000
Nov 26, 2024	Sell -- (Common Stock)	134713	0.27	41070
Nov 1, 2024	M -- (Common Stock)	40125	0	175783
Jun 6, 2024	Acquisition -- (Common Stock)	4000	0	135658
Apr 2, 2024	F -- (Common Stock)	14052	5.12	131658
Apr 1, 2024	M -- (Common Stock)	6000	0	106144
Apr 1, 2024	M -- (Common Stock)	39566	0	145710
Nov 2, 2023	F -- (Common Stock)	13401	2.22	100144
Nov 1, 2023	M -- (Common Stock)	40125	0	113545
Apr 4, 2023	F -- (Common Stock)	1852	2.58	73420
Apr 1, 2023	M -- (Common Stock)	6000	0	75272